Related Experiment Video
Updated: Aug 23, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Lung transplantation for coronavirus disease 2019 associated severe acute respiratory distress syndrome
Rafael Garza-Castillon1, Ankit Bharat1,2
1Division of Thoracic Surgery.
Purpose Of Review:
The purpose of this review is to analyze the most recent and relevant literature involving lung transplantation for coronavirus disease 2019 (COVID-19) associated acute respiratory distress syndrome (ARDS), the pathological mechanisms of lung injury, selection criteria and outcomes.
Recent Findings:
Pathological analysis of lungs after COVID-19 ARDS has shown architectural distortion similar to that observed in explanted lungs from patients undergoing lung transplantation for end-stage lung diseases such as emphysema. Short-term outcomes after lung transplantation for COVID-19 associated respiratory failure are comparable to those performed for other indications.
Summary:
Lung transplantation after COVID-19 ARDS is a potentially life-saving procedure for appropriately selected patients with no evidence of lung function recovery despite maximal treatment. Lung transplantation should be ideally performed in high-volume centers with expertise.
Insights
Lung transplantation can be a life-saving option for severe coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) patients who do not recover lung function. Outcomes are comparable to other lung transplant indications when performed at expert centers.
Area of Science:
- Pulmonology
- Transplant Surgery
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) can lead to severe acute respiratory distress syndrome (ARDS) requiring advanced respiratory support.
- Lung transplantation is being considered for select COVID-19 ARDS patients with irreversible lung damage.
- Understanding the pathological mechanisms and outcomes is crucial for guiding treatment decisions.
Approach:
- This review analyzes recent literature on lung transplantation for COVID-19 ARDS.
- It examines pathological findings in explanted lungs.
- Selection criteria and patient outcomes are evaluated.
Key Points:
- Pathological changes in COVID-19 ARDS lungs resemble those seen in other end-stage lung diseases.
- Short-term outcomes for lung transplantation in COVID-19 ARDS are comparable to those for other indications.
- Successful transplantation requires careful patient selection and high-volume center expertise.
Conclusions:
- Lung transplantation offers a potentially life-saving intervention for COVID-19 ARDS patients unresponsive to maximal therapy.
- It is a viable option for carefully selected individuals with no signs of lung recovery.
- Performing these complex procedures at experienced, high-volume centers is recommended.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Kidney Transplant II: Surgical Procedure

